Comparative Study
Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission
Affiliations
- PMID: 1968895
Item in Clipboard
Comparative Study
Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission
Isr J Med Sci.
1990 Jan.
No abstract available
Similar articles
-
Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.Am J Gastroenterol. 1988 Jan;83(1):15-9. Am J Gastroenterol. 1988. PMID: 2892391 Clinical Trial.
-
Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.Aliment Pharmacol Ther. 1989 Apr;3(2):183-91. Aliment Pharmacol Ther. 1989. PMID: 2577483 Clinical Trial.
-
5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.Ital J Gastroenterol. 1994 Apr;26(3):121-5. Ital J Gastroenterol. 1994. PMID: 7914759 Clinical Trial.
-
Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.Rev Gastroenterol Disord. 2006 Spring;6(2):97-105. Rev Gastroenterol Disord. 2006. PMID: 16699478 Review.
-
Sulfasalazine and new analogues.Am J Gastroenterol. 1986 Feb;81(2):141-4. Am J Gastroenterol. 1986. PMID: 2868653 Review. No abstract available.
Cited by
-
A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis.Dig Dis Sci. 2009 Jun;54(6):1157-70. doi: 10.1007/s10620-008-0481-x. Epub 2008 Sep 4. Dig Dis Sci. 2009. PMID: 18770034 Review.
-
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.Cochrane Database Syst Rev. 2016 May 9;2016(5):CD000544. doi: 10.1002/14651858.CD000544.pub4. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Aug 28;8:CD000544. doi: 10.1002/14651858.CD000544.pub5. PMID: 27158764 Free PMC article. Updated.
-
New salicylates as maintenance treatment in ulcerative colitis.Gut. 1994 Sep;35(9):1155-8. doi: 10.1136/gut.35.9.1155. Gut. 1994. PMID: 7959217 Free PMC article. No abstract available.
-
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.Cochrane Database Syst Rev. 2020 Aug 28;8(8):CD000544. doi: 10.1002/14651858.CD000544.pub5. Cochrane Database Syst Rev. 2020. PMID: 32856298 Free PMC article.
-
Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses.Lancet Gastroenterol Hepatol. 2018 Nov;3(11):742-753. doi: 10.1016/S2468-1253(18)30231-0. Epub 2018 Aug 17. Lancet Gastroenterol Hepatol. 2018. PMID: 30122356 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical